Pierre Fenaux

21PUBLICATIONS
98CO-AUTHORS
Social epidemiologyRespiratory diseasesHaematological tumoursMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 30, 2026
The Predictive Value of Serum Erythropoietin Levels Measured at Diagnosis in Patients With Myelodysplastic Syndromes.

|Feb 18, 2026
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies.

Aleksandar Savic, Adele Taylor, Pierre Fenaux

|Jul 02, 2025
Efficacy and safety of luspatercept with or without erythropoiesis-stimulating agent in patients with myelodysplastic neoplasms with ring sideroblasts: A multicentre real-life study by the GFM.

Maud D'Aveni, Laurence Schenone, Jose Miguel Torregrosa

|Dec 19, 2024
Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasm.

Stéphane De Botton, Christian Récher, Jorge Cortes

|Aug 01, 2024
Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin C.

Zhiliang Hei, Shujun Yang, Guifang Ouyang

|Dec 22, 2022
Reduced murine double minute 2 and 4 protein, but not messenger RNA, expression is associated with more severe disease in myelodysplastic syndromes and acute myeloblastic leukaemia.

Norman Salomao, Nabih Maslah, Anouk Giulianelli

Pageof 4

Frequent Collaborators

3 joint publications

Saskia Langemeijer

3 joint publications

Argiris Symeonidis

3 joint publications

Lionel Adès

3 joint publications

Maud D'Aveni